Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
Recruiting now
Conditions studied: Intracranial Atherosclerosis, Optical Coherence Tomography, Plaque, Atherosclerotic, Artery Stenosis, Ischemic Stroke
In brief
To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).
Key facts
- Study ID
- NCT05550077
- Run by
- jiaoliqun
- People needed
- 400
- Starts
- 2020-03-15
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2022-09-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Symptomatic ICAS. Participants with ICAS with a transient ischaemic attack (TIA) or stroke attributable to the territory of the stenotic artery were defined as symptomatic. A TIA was defined as a transient episode of neurological dysfunction (focal weakness or language disturbance, transient monocular blindness, or required assistance in walking) caused by focal brain or retinal ischaemia that lasted for at least 10 minutes but resolved within 24 hours
- Stenotic degree ≥ 50%, measured by digital subtraction angiography
- The stenosis must located in at least one major intracranial artery (internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery)
You may not qualify if…
- Arteriovenous Malformation
- Aneurysm
Where it is running
- Xuanwu Hospital, Capital Medical University — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.